| Net earnings | 296M |
| Earnings from discontinued operations | 6M |
| Depreciation | 372M |
| Amortization of intangibles and other deferred items | |
| Amortization of finance fees and debt discount | |
| Deferred tax benefit | |
| Restructuring | |
| Other | -89M |
| Asbestos-related payments | -45M |
| Cash paid for restructuring activities | -20M |
| Change in non-current operating assets | |
| Change in non-current liabilities | |
| Change in components of working capital | -320M |
| Cash provided by continuing operating activities | 226M |
| Cash provided by discontinued operating activities | -6M |
| Total cash provided by operating activities | 220M |
| Additions to property, plant, and equipment - continuing | -310M |
| Additions to property, plant, and equipment - discontinued | |
| Acquisitions, net of cash acquired | -45M |
| Cash utilized in investing activities | -282M |
| Additions to long-term debt | |
| Repayments of long-term debt | |
| Increase (decrease) in short-term loans - continuing | |
| Decrease in short-term loans - discontinued | |
| Net receipts (payments) for hedging activity | |
| Payment of finance fees | -3M |
| Dividends paid to noncontrolling interests | |
| Treasury shares purchased | 0 |
| Issuance of common stock and other | 5M |
| Cash utilized in financing activities | -39M |
| Effect of exchange rate fluctuations on cash | -4M |
| Decrease in cash | -105M |
| Cash at beginning of period | 399M |
| Cash at end of period | 294M |
| Cash - discontinued operations | |
| Cash - continuing operations | |